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Abstract
Background: Primary hepatocyte cultures are a valuable tool for the understanding of cellular and
molecular phenomena occurring during malaria liver stage. This paper describes an improved
perfusion/dissociation procedure to isolate hepatocytes from mouse liver that is suitable for
malaria studies and allows reproducible preparation of primary hepatocytes with consistent cell
yields and controlled purity.
Results: This protocol is a detailed description of a technique to isolate and culture mouse
hepatocytes and represents an improvement over previous descriptions of hepatocyte isolation for
malaria studies, regarding three technical aspects: (1) dissociation reagents choice; (2) cell
separation gradient and (3) cell purity control. Cell dissociation was optimized for a specific
collagenase digestion media. The cell dissociation step was improved by using a three-layer
discontinuous gradient. A cell purity check was introduced to monitor the expression of CD95 on
hepatocytes using flow cytometry methods.
Conclusion: The procedure described allows reproducible recovery of one to three million
hepatocytes per preparation with cell purity of about 90% as determined by FACS analysis.
Completion of the protocol is usually achieved in about four hours per preparation and pooling is
suggested for multiple preparations of larger number of cells.
Background
Hepatocytes represent the vast majority of liver cells and
are responsible for the main specific hepatic functions,
such as carbohydrate transformation, bile production and
protein production and storage. In the course of malaria
infection, hepatocytes are a critical site for malaria para-
site to establish themselves in the mammalian host.
Within hepatocytes, individual parasites occupy a single
vacuole, in which it grows rapidly and produces the first
generation of red blood cell-infectious merozoite forms.
The intrahepatic stage takes, approximately 42 h in
rodents and 5–10 days in human malaria, allowing for
extensive cellular and molecular interactions between par-
asite and host [1-4]. To study these exo-erythrocytic stages
of malaria parasites, several in vitro model systems have
been developed using human and rodent hepatocyte cell
lines. Immortalized cells are easy to manipulate, but have
obvious limitations as they show significantly divergent
behaviour as compared to primary hepatocyte cultures
and  in vivo infection [5]. Moreover, it is expected that
hepatocyte infection by Plasmodium differs depending on
the host genetic background [6]. In this context, primary
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hepatocytes are a valuable tool for the understanding of
cellular and molecular phenomena occurring during
malaria liver stage. This protocol describes an efficient and
reproducible procedure based on perfusion/dissociation
procedure to isolate and culture primary hepatocytes for
malaria liver stage studies.
The saga of hepatocyte isolation began 40 years ago with
a steadily improvement of preparation methods including
applications of the technique to malaria parasite studies
[7-9]. The method for preparation of intact hepatocytes
was first described in 1969 [10] and since then has under-
gone many modifications. The most commonly used
technique was introduced in 1976 and relies on a two-
step procedure, including in situ perfusion and purifica-
tion based on cell density [11]. Perfusion uses Ca2+ free
medium, critical for cell separation, and subsequently
Ca2+  rich medium containing Ca2+  dependent colla-
genase, for digestion. Appropriate collagenase treatment
is absolutely crucial for hepatocyte preparation. Fre-
quently, the difficulties in obtaining good cell dissocia-
tion are attributed to crude collagenase contamination
with other proteases, which varies depending on the
batch. Incidentally, some of these contaminant proteases
appear to be required for good cell isolation, but their
identity is still uncertain [12]. Another critical step is
hepatocyte enrichment. Almost all existing purification
protocols for murine primary hepatocytes rely on centrif-
ugation through a discontinuous 60% (1.076 g/ml) Per-
coll gradient [13]. This is intended to remove non-
parenchymal cells, death cells and cell debris, but the
degree of purity of hepatocyte preparations has been diffi-
cult to access.
Here, a complete description of this technique is provided
and introduced a number of improvements over pub-
lished techniques allowing reproducible hepatocyte isola-
tion, consistent cell yields and quantification of final
hepatocyte enrichment. The optimization started by the
testing of several collagenase batches and modified the
protocol for a commercially available collagenase
medium (Hepatocyte Liver Digest Medium from Gibco).
After, different Percoll densities configurations were tested
until was accomplished superior hepatocyte separation,
using a three-layer discontinuous Percoll gradient [14]. In
addition, a hepatocyte purity control by flow cytometry
analysis was introduced. Mouse hepatocytes prepared by
this method are suitable for Plasmodium infection as well
as immunohistochemistry, gene expression and gene
functional studies on monolayer primary cultures.
Results
Perfusion apparatus setup
The perfusion system uses a peristaltic pump with adjust-
able speed. The system is setup by mounting the peristaltic
pump with long silicone tubing immersed in a water bath.
The water bath temperature is adjusted so that the per-
fusion fluid is at 37°C at the tube outlet. The pump speed
must be set at constant flow of 6 ml/min. To prepare the
liver lobes perfusion is necessary to attach an Abocat (18
G and 30 mm length) to the tube outlet end and fill the
tubing with Hepatocyte Liver Perfusion Medium (1x)
(Gibco).
Reagent setup
The method uses different reagents that should be pre-
pared in advance.
Percoll solutions
Three different Percoll density solutions are used (1.12 g/
ml, 1.08 g/ml and 1.06 g/ml). For 1.12 g/ml solution we
used 2.63 ml of Percoll, 0.3 ml of PBS (10x) and 64.6 µl
of water; for 1.08 g/ml solution we used 2.86 ml of Per-
coll, 0.5 ml of PBS (10x) and for 1.63 ml of water and for
1.06 g/ml solution we used 2.085 ml of Percoll, 0.5 ml of
PBS (10x) and 2.42 ml of water. These solutions must be
kept at room temperature.
Cell culture media
Two different media were prepared for the primary hepa-
tocyte cultures: Williams' Complete medium (WCM), that
was prepared by adding to Williams' Medium E (1x) with
GlutaMAX I (Gibco) 4% of Foetal Calf Serum (Gibco) and
1% Penicillin/Streptomycin (Gibco); and Williams' Sup-
plemented medium (WSM), that was prepared by adding
to Williams' Medium E (1x) with GlutaMAX I (Gibco) 4%
of Foetal Calf Serum (Gibco), 1% Penicillin/Streptomycin
(Gibco), 50 ng/ml of Epidermal Growth Factor (BD), 1
µg/ml Insulin (Sigma), 10 µg/ml of Transferrin (Sigma),
and 1.3 µg/ml of Hydrocortisone (BD).
Plate coating
A 0.2% solution of gelatine was prepared by mixing 1 g of
gelatine (Merck) in 500 ml of PBS (1x), dissolved by heat-
ing above 60°C and filter-sterilized. This solution was
used to coat 24 well plates (200 mm2/well) with 400 µl
per well. The plates were let open and air drying for about
30 min in a laminar flow cabinet, then the liquid excess
was rejected, avoiding scratching the gelatine surface and
the plate was air dried for additional 30 min.
Liver dissection
The hepatocytes were isolated from adult mouse livers (8–
14 week of age). All animal procedures were in accordance
with applicable regulations on animal experimentation
and welfare. This procedure was approved by the Animal
Care and Use Committee, at the Instituto Gulbenkian de
Ciência. The liver lobe is dissected by opening the perito-
neal cavity and using surgery scissors (straight tip and cut-
ting edge around 40 mm long, appropriate for soft tissues)Malaria Journal 2007, 6:169 http://www.malariajournal.com/content/6/1/169
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to cut the left liver lobe. The cut of the liver lobe should be
done with a single cut and in such a manner that the main
blood vessel of the lobe is exposed, as shown in Figure 1.
The liver lobe was then collected into a 15 ml Falcon tube
containing 5 ml of Williams Medium E (1x) with
GlutaMAX I (Gibco).
Liver perfusion
After liver dissection, the liver lobe was transferred onto a
piece of gauze placed on the hand. The tip of an Abocat
needle (18 G and 30 mm length) was introduced into the
main blood vessel and the perfusion was started using
Hepatocyte Liver Perfusion Medium (1x) (Gibco). The
perfusion was kept until the liver lobe is drained off blood
and appears pale, at this stage the Hepatocyte Liver Per-
fusion Medium was changed to Hepatocyte Liver Digest
Medium (1x) (Gibco). It is useful, at this stage, to let an
air bubble enter the tubing as this helps to keep the two
media apart inside the tubing. Perfusion with Hepatocyte
Liver Digest Medium (1x) (Gibco) was kept until the liver
lobe felt very soft. This is a critical step, as this medium
contains collagenase, and excessive digestion should be
avoid to prevent cell death (Table 1). Normally, 30 ml of
Hepatocyte Liver Digest Medium were enough for proper
digestion.
Cell dissociation
Subsequently to liver digestion, the perfused liver lobe
was transferred to a Petri dish containing 10 ml of Hepa-
tocyte Liver Perfusion Medium. Then, with the help of two
1 ml pipettes the liver capsule disrupted. At this stage it is
possible to check the perfusion success as upon liver cap-
sule disruption, a fine cloud of cells should spread in the
medium as a sign of successful dissociation. Poor cell dis-
sociation usually can be improved by perfusion optimiza-
tion (Table 1).
The cell suspension was forced through a 100 µm Cell
Strainer (BD) into a 50 ml Falcon tube. The tube was filled
up to 30 ml with Hepatocyte Liver Perfusion Medium, and
centrifuged at 135 g for 30 seconds. At this point, one can
choose either to ressuspend the pellet in 24 ml of WCM
and move on to the fractionation step or to ressuspend the
cells in 3 ml of WCM and store them at 4°C, while contin-
uing to perfuse another mouse liver lobe. Dissociated cells
from successive liver digestions can be pooled up to a final
volume of 24 ml.
Hepatocyte isolation
For each 24 ml suspension of dissociated cells, is neces-
sary to mount four Percoll gradient tubes. Using the pre-
viously prepared Percoll solutions, 3 ml of 1.12 g/ml
solution was applied on the bottom of a polystyrene con-
ical tube (30 ml Universal, Sterilin), over which 5 ml of
1.08 g/ml solution was carefully laid. Finally, 5 ml of 1.06
g/ml solution was laid. Handling of the prepared gradi-
ents should avoid mixing the density layers.
Cell suspension was applied over the Percoll gradient by
carefully laying 6 ml of cell suspension in each gradient
Liver cutting Figure 1
Liver cutting. (a) Left lobe, indicated by arrow. (b) Excision of liver lobe with a single cut, exposing the main blood vessel as 
shown in (c).Malaria Journal 2007, 6:169 http://www.malariajournal.com/content/6/1/169
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tube, avoiding gradient disturbance (Table 1). The cell
suspension was fractionated by centrifugation at 750 g
during 20 min, without brake, at 20°C (Percoll solutions
should not be centrifuged below 20°C). After Percoll gra-
dient centrifugation the two upper layers that contain cell
debris and non-parenchymal cells were carefully pipetted
out and discarded. Then, the lowest layer that contains the
live hepatocytes was collected from the four Percoll gradi-
ent tubes and dispensed in two 50 ml Falcon tubes previ-
ously containing 10 ml of WCM. The Falcon tubes were
filled up to 40 ml of volume of WCM before centrifuga-
tion at 355 g (20°C) during 10 min. Subsequently, the
cell pellets from the two Falcon tubes were ressuspend
and pooled in a final volume of 6 ml of WCM. For the sec-
ond round of cell isolation, an additional Percoll gradient
tube was prepared. This second gradient step significantly
increases cell purity (Figure 2). Similarly to the first round,
the cell suspension was applied over the Percoll gradient,
and centrifuge at 750 g during 20 min, without brake. The
two upper layers were discarded and the lowest cell layer
was collected in a 15 ml Falcon tube. To wash the cells the
tube was filled up with WCM, centrifuged at 355 g (4°C)
10 min and the pellet was ressuspend in 15 ml of WCM.
The washing was repeated and the pellet was ressuspend
in 1 ml of WCM.
Purity control
To evaluate the hepatocyte enrichment of these prepara-
tions we used FACS analysis (Figure 2) and stained cells at
different steps of the hepatocyte isolation procedure with
anti-CD95 PE, CD45RB-biotin and streptavidin-APC
from BD-Pharmingen, The hepatocyte morphological
gate was defined on basis of size and confirmed by the
presence of high frequency of CD95 low cells. In fact,
CD95 is expressed at low levels by hepatocytes and its
expression is not detectable in other cell types present in
the liver. To detect the presence of other contaminating
large cells within the hepatocyte gate we used the CD45RB
monocytes/macrophage lineage marker.
Hepatocyte plating
Viable hepatocytes were counted on a haemocytometer,
using trypan blue staining. Depending on cell yield and
experiment design 5 × 104 to 1 × 105 hepatocytes were
used in each culture well in a volume of 700 µl of WCM.
The cell suspension was distributed in the pre-coated 24
well plates, the cells were let to adhere for 4 h in the incu-
bator (37°C and 5% CO2) and then changed to WSM.
Viability assessment
Viability of isolate hepatocytes estimated by trypan blue
staining is usually 80–90%. Viability of hepatocyte cul-
tures was also monitored during 8 days in culture by FACS
analysis using propidium iodide staining. Briefly, cells in
culture were detached by standard Trypsin/EDTA treat-
ment, centrifuged, suspended in PBS and stained with
propidium iodide 10 µg/ml. Percent of propidium iodide
positive cells were detected in the FL3 channel of a FACS-
calibur instrument (Becton & Dickinson). It is likely that
the detachment procedure induces some cell death, but
the results indicate that the hepatocyte culture maintains
stable viability during at least 8 days (Figure 3).
Development of Plasmodium exo-erythrocytic forms
To show that the hepatocyte cultures sustain the develop-
ment of parasite liver stages, a time-course experiment was
performed that quantified the parasite growth in sporo-
zoites-infected cultures (Figure 4). Plasmodium berghei
ANKA sporozoites were obtained from dissection of sali-
vary glands from infected female Anopheles stephensi mos-
quitoes. Sporozoites suspensions in RPMI medium added
at concentration of 3 × 104 sporozoites per culture well.
Parasite rRNA was quantified by real-time PCR. Briefly,
cells were collected at indicated times, with the help of a
cell scraper, immediately homogenized in denaturing
solution (4M guanidine thiocyanate, 25 mM sodium cit-
rate pH 7.0, 0.5% sarcosyl and 0.7 % β-mercaptoethanol
in DEPC treated water) and total RNA was obtained using
RNeasy Mini Kit (Qiagen). One microgram of total RNA
was converted to cDNA (Transcriptor First Strand cDNA
Table 1: Frequent causes unsuccessful hepatocyte isolation.
Step Problem Possible Reason Solution
Perfusion Poor cell dissociation Poor digestion Make sure the Digestion solution is at 37°C
Tissue disruption Lower down perfusion speed
Cell death Excessive collagenase digestion Reduce the time/volume of perfusion with Hepatocyte Liver 
Digest Medium
Cell isolation Low recovery To many cells loaded on the gradient If using more than three lobes, increase the number of gradient 
tubes
Gradient disturbance Setup new gradient, making sure the layers do not mix
Altered gradient densities Check that the gradient centrifugation temperature is kept at 
20°C and Percoll solutions at room temperatureMalaria Journal 2007, 6:169 http://www.malariajournal.com/content/6/1/169
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Synthesis Kit, Roche) and cDNA specific to P. berghei 18S
rRNA was amplified with primers NYU-Pb1 5'-AAG CAT
TAA ATA AAG CGA ATA CAT CCT TAC-3' and NYU-Pb2
5'-GGA GAT TGG TTT TGA CGT TTA TGT-3'. The real-time
PCR reactions were performed in ABI Prism 7900HT sys-
tem using ABI Power SYBR Green PCR Master Mix. Abso-
lute P. berghei 18S rRNA estimates were normalized for
mRNA of Hypoxanthine Guanine Phosphoribosyl-trans-
ferase (HPRT), a mouse housekeeping gene. Parasite liver
stages development is also detectable by fluorescent
microscopy of hepatocytes infected with sporozoites from
green fluorescent protein (GFP)-transgenic P. berghei
ANKA (Figure 5b).
Immunofluorescence labeling and transfection of 
hepatocytes
Cell transfection was performed with Lipofectamine (Inv-
itrogen) or Fugene6 (Roche) according to manufacture
guidelines. Briefly, 0.5 mg of an EGFP-tagged DNA vector
(Invitrogen) was mixed with 2.5 µl of Lipofectamine and
Cells culture viability Figure 3
Cells culture viability. Time-course analysis of cell survival in 
hepatocyte cultures. Dead cells were measured as positive 
cells to propidium iodide staining in flow cytometry analysis.
Checking hepatocyte enrichment by flow cytometry analysis Figure 2
Checking hepatocyte enrichment by flow cytometry analysis. (a) Enrichment of cells within the hepatocyte gate and loss of cell 
debris along the hepatocyte isolation procedure (perfusion, first and second gradient step). (b) The enriched hepatocyte prep-
aration of the second gradient step is also enriched for cells not expressing CD45RB and expressing CD95 at low levels.Malaria Journal 2007, 6:169 http://www.malariajournal.com/content/6/1/169
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200 µl of Optimem (Invitrogen) or 1 mg of an EGFP-
tagged DNA vector was mixed with 5 µl of Fugene6 and
200 µl of Optimem, mixtures were allowed to rest for 15
minutes at room temperature and added to cells. Cells
were left in transfection mixture for three hours at 37°C
before the medium was changed to normal growth
medium. Cells were left to express the EGFP tagged DNA
for 24 hours before cell fixation (Figure 5d).
For immunofluorescence labeling, cells were fixed in 4%
paraformaldehyde (Sigma) in PBS. Fixed cells were per-
meabilized and blocked with 0.05% saponin (Sigma) 1%
foetal calf serum (Invitrogen) and 1% bovine serum albu-
min (Sigma), for 30 minutes at 37°C. Adequate primary
antibodies were incubated in the same solution as above
and left for one hour. All secondary antibodies were
obtained from Invitrogen and used at a dilution of 1:400
in the same solution as above (Figure 5c). Cells were
mounted on MOWIOL (Calbiochem). Images were
acquired using a Leica SP5 confocal microscope.
Cell biology applications of cultured hepatocytes Figure 5
Cell biology applications of cultured hepatocytes. (a) Light microscopy image of a hepatocyte monolayer at 24 h culture. (b) 
Immunofluorescence image of hepatocytes 36 h after infection with GFP-expressing Plasmodium berghei and DAPI staining. (c) 
Confocal image of hepatocyte stained with monoclonal antibodies to Transferrin receptor labelled with Alexa488 (Invitrogen). 
d) Confocal image of hepatocyte transfected with an EGFP construct using Lipofectamine reagent (Invitrogen). Bars, 20 µm.
Plasmodium quantification in hepatocyte culture Figure 4
Plasmodium quantification in hepatocyte culture. P. berghei 
18S rRNA was quantified by real-time PCR in cultured hepa-
tocytes of C57Bl/6 mice at the indicated times after infection 
with 3 × 104 sporozoites at 24 h post-plating.Malaria Journal 2007, 6:169 http://www.malariajournal.com/content/6/1/169
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Discussion
The hepatocyte enrichment here described is obtained by
two successive gradients entail a net cell loss. This proce-
dure usually allows recovery of about 1–3 × 106 cells per
liver lobe. However, the recovery yield may vary signifi-
cantly, depending on the mouse strain. Routinely, were
obtain cell preparations containing 90% of hepatocytes,
and cell debris was about 10% or less of the detected
events according to flow cytometry criteria (Figure 2).
After labelling with CD45RB and Fas (CD95), hepatocytes
can be identified in flow cytometry as cells having high
side scatter, low expression of CD45RB and constitutively
expressing CD95 [15,16]. In fact, these cell preparations
are amenable for flow cytometry analysis, either on
freshly isolated cells or after culture (standard Trypsin/
EDTA treatment can be used to detach cultured cells).
Cells for infection with malaria liver stage sporozoites
should be kept at least 24 h in culture in WCM. This
allows the formation of a stable cell monolayer (Figures
5a and 5b), if enough cells are put initially in culture.
When the goal is to infect at 24 h post-plating it is advisa-
ble to plate no less than 1 × 105 cells in a 200 mm2 well
(e.g. 24 well plates). To infect after 48 h post-plating, is
advisable to start with less cells (5 × 104) and maintain the
cells in WSM until 12 h before infection, after which the
medium must be changed to WCM, allowing the cells to
proliferate (Figure 6) and achieve confluence on a monol-
ayer. Hepatocytes cultured in WSM are stable for about
one week (Figure 3), after which they start to die and loose
typical characteristics. These hepatocyte cultures sustain
Plasmodium  liver forms development that is detectable
both by molecular methods (Figure 4) and microscopy
examination (Figure 5b).
The cultured cells when attached resist well to manipula-
tion, allowing immunohistochemistry procedures and
transfection assays (Figures 5c and 5d). The experience
shown that these cells are better transfected when using
Lipofectamine rather Fugene (20% vs. 6% transfection
rate). After culture, it is also feasible to collect cells with
the help of a cell scraper and RNA lysis solution, and
extract RNA for hepatocyte and parasite gene expression
analysis.
Although hepatocytes prepared with this technique can be
successful used for a range of biological applications it is
difficult to directly compare it with the performance of
other preparation methods where relevant amounts of
other cell types may distort estimations of cell viability,
cell counting and cell proliferation.
Authors' contributions
LAG conceived the protocol, designed and performed the
experiments, drafted the manuscript. AMV gave assistance
to LAG. CPG participated in study design and coordina-
tion and drafted the manuscript. All authors read and
approved the final manuscript.
Hepatocyte proliferation Figure 6
Hepatocyte proliferation. Flow cytometry analysis of hepatocyte proliferation, measured by BrdU incorporation after 72 hours 
of continuous labelling. The plots show considerable increase in cell proliferation when the cells are cultured in Williams sup-
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